Ann Surg Treat Res.
2024 Nov;107(5):252-263. 10.4174/astr.2024.107.5.252.
The efficacy of exosomes from human chemically derived hepatic progenitors in liver damage alleviation: a preclinical experimental study
- Affiliations
-
- 1Department of Surgery, Hanyang University College of Medicine, Seoul, Korea
- 2Research Institute of Regenerative Medicine and Stem Cells, Hanyang University, Seoul, Korea
- 3Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Korea
- KMID: 2560739
- DOI: http://doi.org/10.4174/astr.2024.107.5.252
Abstract
- Purpose
Over the past decade, interest in exosomes as therapeutics has surged. In particular, stem-cell–derived exosomes may be more effective as a treatment for liver disease than the stem cells themselves. We have previously developed human chemically derived hepatic progenitors (hCdHs) from human hepatocytes. hCdHs can differentiate into hepatocytes and cholangiocytes, regenerating the liver in mouse models. In this study, we evaluated the mitigating effects of hCdHs-derived exosomes (hCdHs-exo) on liver damage and compared them with those of exosomes from bone marrow mesenchymal stem cells (BMMSCs-exo).
Methods
Exosomes were isolated from hCdHs and BMMSCs by culturing cells in large quantities and separating the exosomes from the culture medium using ultracentrifugation. Isolated exosomes were characterized by various methods before experimental use. In vitro, the ability of exosomes to inhibit activation of hepatic stellate cells (HSCs) by transforming growth factor beta 1 was evaluated. In vivo, exosomes were injected into mice with carbon tetrachloride (CCl4 )-induced liver damage, and their effectiveness in mitigating liver damage was assessed by histological staining and biochemical analysis.
Results
The analyses confirmed the successful isolation of exosomes from both cell types. In vitro, hCdHs-exo significantly reduced the levels of transcription factors and activation markers in induced HSCs. In vivo, hCdHs-exo effectively alleviated liver damage caused by CCl4 . Furthermore, both in vitro and in vivo studies confirmed that hCdHs-exo had a greater effect in alleviating liver damage than did BMMSCs-exo.
Conclusion
These results demonstrate that hCdHs-exo, similarly to hCdHs, have superior efficacy in alleviating liver damage compared with BMMSCs-exo.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Enhancing generation efficiency of liver organoids in a collagen scaffold using human chemically derived hepatic progenitors
- Expandable liver organoids generated from human chemically derived hepatic progenitor enable alcoholic liver modeling
- Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
- Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
- Non-viral ex vivo therapeutic strategy in chemically derived hepatic progenitor with adenine base editor and prime editor
